Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Low-dose flutamide helps reduce excessive hair growth and is even more effective with birth control, without bad effects on blood fats.

Leflunomide successfully treated a rare skin condition in a liver transplant patient.

Sintilimab with chemotherapy improves survival and response in advanced lung cancer but increases some side effects.

Olumiant should be covered for severe alopecia areata if certain conditions are met.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.

The LTF gene may help predict and manage nonspecific orbital inflammation.

Fremanezumab effectively reduces migraines and improves quality of life with mild side effects.

Ritlecitinib significantly regrows scalp hair in people with alopecia areata.

The new drug delivery system improves bicalutamide skin retention for better treatment of hair loss.

A PTH-based treatment improved hair regrowth better than ruxolitinib in a mouse model of hair loss.

Bevacizumab may worsen hypothyroidism, so thyroid function should be monitored during treatment.

Early diagnosis and treatment are crucial for managing Berardinelli–Seip syndrome.

Tofacitinib is effective and safe for elderly patients with ulcerative colitis.

Baricitinib and ritlecitinib are both effective and safe for treating severe alopecia areata.

Oral tofacitinib significantly improves lichen planopilaris symptoms without adverse effects.

Bicalutamide may be a promising alternative treatment for female pattern hair loss.

Careful monitoring is crucial to prevent JC virus reactivation in lupus patients treated with rituximab.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

Horizant has risks like other seizure drugs, Johnson & Johnson misled about Risperdal, and Quanterix found a possible link between brain oxygen loss and Alzheimer's markers.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

IVIG therapy significantly improved symptoms in a patient with APS-2 and SPS.

Lactium, a milk protein, can help reduce symptoms of skin disorders linked to stress and anxiety without side effects.

Upadacitinib effectively treated alopecia areata when other treatments failed.

Rimegepant causes more nausea and skin issues, while ubrogepant causes more muscle issues; personalized treatment is important.

CTP-543 significantly improved eyebrow and eyelash regrowth and patient satisfaction in adults with alopecia areata.

Individualized treatments may help manage Dercum's disease symptoms.